SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Us Bio Tech informs about newspaper advertisement

13 Aug 2025 Evaluate

Indo Us Bio Tech has submitted the Newspaper Advertisement relating to the Unaudited Quarterly Standalone Financial Results for the quarter ended on 30th June, 2025 published in Western times - English and Western times - Gujarati Newspaper to comply Regulation 47 of SEBI LODR Regulations.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

106.61 -0.57 (-0.53%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1478.75
Mangalam Global Ent 12.55
Kaveri Seed 927.05
Regaal Resources 78.46
Simran Farms 156.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×